TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 750nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 750nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 750nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: <100nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: >1.00E+3nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Sk Biopharmaceuticals
US Patent
Sk Biopharmaceuticals
US Patent
Affinity DataEC50: 300nMAssay Description:Activity of heteromeric α7 nAChR was measured via FlexStation-Ca2+ influx assay. In the present example, in consideration of α7 nAChR being...More data for this Ligand-Target Pair